IBDEI10N ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18110,2)
 ;;=^339690
 ;;^UTILITY(U,$J,358.3,18111,0)
 ;;=V58.61^^98^1028^23
 ;;^UTILITY(U,$J,358.3,18111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18111,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,18111,1,5,0)
 ;;=5^L/T (Current) Anticoagulant Use
 ;;^UTILITY(U,$J,358.3,18111,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,18112,0)
 ;;=V58.62^^98^1028^22
 ;;^UTILITY(U,$J,358.3,18112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18112,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,18112,1,5,0)
 ;;=5^L/T (Current) Antibiotics Use
 ;;^UTILITY(U,$J,358.3,18112,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,18113,0)
 ;;=V58.63^^98^1028^24
 ;;^UTILITY(U,$J,358.3,18113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18113,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,18113,1,5,0)
 ;;=5^L/T (Current) Antiplts/Antithrmbtcs
 ;;^UTILITY(U,$J,358.3,18113,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,18114,0)
 ;;=V58.64^^98^1028^28
 ;;^UTILITY(U,$J,358.3,18114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18114,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,18114,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,18114,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,18115,0)
 ;;=V58.65^^98^1028^30
 ;;^UTILITY(U,$J,358.3,18115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18115,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,18115,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,18115,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,18116,0)
 ;;=V58.66^^98^1028^25
 ;;^UTILITY(U,$J,358.3,18116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18116,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,18116,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,18116,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,18117,0)
 ;;=V58.67^^98^1028^27
 ;;^UTILITY(U,$J,358.3,18117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18117,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,18117,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,18117,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,18118,0)
 ;;=V58.68^^98^1028^26
 ;;^UTILITY(U,$J,358.3,18118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18118,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,18118,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,18118,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,18119,0)
 ;;=V58.69^^98^1028^29
 ;;^UTILITY(U,$J,358.3,18119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18119,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,18119,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,18119,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,18120,0)
 ;;=V58.83^^98^1028^50
 ;;^UTILITY(U,$J,358.3,18120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18120,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,18120,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,18120,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,18121,0)
 ;;=V62.5^^98^1028^32
 ;;^UTILITY(U,$J,358.3,18121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18121,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,18121,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,18121,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,18122,0)
 ;;=V79.1^^98^1029^1
 ;;^UTILITY(U,$J,358.3,18122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18122,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,18122,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,18122,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,18123,0)
 ;;=V61.21^^98^1029^8
 ;;^UTILITY(U,$J,358.3,18123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18123,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,18123,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,18123,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,18124,0)
 ;;=V65.40^^98^1029^2
